Supplemental material
Postgraduate Medicine
Volume 133, 2021 - Issue 1
Clinical Features - <italic>Original Research</italic>
Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials
Margaret Molinea Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USACorrespondence[email protected]
https://orcid.org/0000-0003-0807-2167
https://orcid.org/0000-0003-0807-2167, Gary Zammitb Clinilabs Drug Development Corporation, New York, New York, USAhttps://orcid.org/0000-0001-8332-6687
https://orcid.org/0000-0001-8332-6687, Jane Yardleyc Neurobiology Business Group, Eisai Ltd., Hatfield, UKhttps://orcid.org/0000-0001-8198-4328
https://orcid.org/0000-0001-8198-4328, Kate Pinnerc Neurobiology Business Group, Eisai Ltd., Hatfield, UKhttps://orcid.org/0000-0002-3475-2708
https://orcid.org/0000-0002-3475-2708, Dinesh Kumara Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USAhttps://orcid.org/0000-0001-5880-4237
https://orcid.org/0000-0001-5880-4237, Carlos Perdomoa Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USAhttps://orcid.org/0000-0001-9307-1833
https://orcid.org/0000-0001-9307-1833 & Jocelyn Y. Chenga Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USAhttps://orcid.org/0000-0001-5318-5668
https://orcid.org/0000-0001-5318-5668 show all